Inspire Investing’s Juno Therapeutics, Inc. JUNO Stock Holding History

Inspire Investing’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,338	Closed	-$61K	–	897
2017 Q4	$61K	Buy	+1,338	New	+$66.7K	0.05%	295

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Inspire Investing's JUNO Position: Q1 2018 in Review

Inspire Investing sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 1,338 shares — an estimated $61K sold.

Inspire Investing first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $61K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Inspire Investing reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Inspire Investing sold 1,338 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $61K.
Inspire Investing first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
Inspire Investing's Juno Therapeutics, Inc. position peaked at $61K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Inspire Investing's 13F filing for Q1 2018, filed 13 Apr 2018.